Provision of medicines supply chain information: supporting ICU medicines supply during COVID-19 response. Phase Two
What the buyer wrote
NHS England & Improvement (NHSE&I) require visibility of the medicines supply chain and national stockholding of priority ICU medicines. Such information supports NHSE&I to allocate and distribute medicines equitably, based on need, to NHS Trusts in England and across the devolved administrations. An understanding of national stock holdings allows us to plan for shortages, manage shortages and engage with industry on areas for priority manufacture. Several medicines are in extremely high demand and the profile of use has changed: COVID-19 treatment requires far higher volumes of certain medicines per patient compared to BAU treatment - primarily due to the length of sedation needed. Addit…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Provision of medicines supply chain information: supporting ICU medicines supply during COVID-19 response. Phase Two
- How they are buying
- Called off an existing agreementThe work went to a supplier already on a framework or dynamic market.
- Type
- services
- Work starts
- 31 May 2020
- Work ends
- 31 Jul 2020
- Kind of work
- Research, evaluation and insight, Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice.